>>> Europe : Brokers Upgrades & Downgrades - 14th of October 2024 V2(+)

>>> Up
* Alfen Raised to Hold at Kepler Cheuvreux
* Bunzl Raised to Overweight at JPMorgan; PT 3,980 pence
* Dometic Raised to Hold at Nordea
* Equinor Raised to Equal-Weight at Morgan Stanley; PT 270 kroner
* Equinor ADRs Raised to Equal-Weight at Morgan Stanley; PT $25.80
* Humana Raised to Buy at Kepler Cheuvreux (+)
* JPMorgan PT Raised to $240 from $225 at Wells Fargo
* Spirax Raised to Buy at Peel Hunt; PT 8,300 pence
* Stora Enso Raised to Neutral at BNPP Exane (+)

>>> Down
* Arcadium Lithium Cut to Hold at TD Cowen; PT $5.85
* BASF Cut to Neutral at UBS (+)
* Caterpillar Cut to Underweight at Morgan Stanley; PT $332
* Compass Group Cut to Neutral at Citi; PT 2,650 pence
* Deutsche PBB Cut to Reduce at AlphaValue/Baader
* Hermes Cut to Market Perform at CICC; PT 2,000 euros
* Ipsen Cut to Hold at Kepler Cheuvreux (+)
* J. Martins Cut to Hold at Bestinver; PT 18.40 euros (+)
* Knorr-Bremse Cut to Sell at Hauck & Aufhaeuser; PT 65.50 euros (+)
* Logista Integral SA Cut to Hold at Kepler Cheuvreux (+)
* Pluxee Cut to Sell at Goldman; PT 18 euros
* TI Fluid Cut to Hold at Investec; PT 200 pence

>>> Initiation
* 1Spatial Rated New Corporate at Cavendish; PT 140 pence (+)
* Argan Rated New Accumulate at KBC Securities; PT 90 euros (+)
* Corem Property Rated New Buy at Pareto Securities
* Diamondback Resumed Neutral at Citi; PT $195
* Galp Rated New Buy at HSBC; PT 20 euros

>>> Call
* JPMorgan Strategists Say Euro-Zone Stocks to Continue to Lag S&P (+)
* Compass Cut at Citi After Strong Run, Aramark Now Top Pick
* Dometic Loses Only Sell; Nordea Says Bad News Probably Priced In (+)
* Equinor Raised, But Morgan Stanley Remains Cautious on Energy
* Goldman Sachs Upgrades China Growth Forecasts on Latest Stimulus
* Hedge Funds Buy US Stocks by Most Since 2021, Goldman Says
* L’Oreal’s Growth May Be Stuck Near-Term, Prefer Beiersdorf: Citi
* TI Fluid’s Latest Offer from ABC Still Looks Low: Jefferies
* Wizz Air Gets Street-Low Price Target as Citi Sees Weak Results

>>> Stoxx 600 Pre-Market Indications

  • ITV (IJ7 TH) +3%
  • Equinor (DNQ TH) +1.8%
    • Equinor Raised, But Morgan Stanley Remains Cautious on Energy
  • Elekta (EJXB TH) +1.5%
  • GSK (GS71 TH) +1.4%
    • GSK Reports Positive Phase 3 Results in Depemokimab Trials
  • Gerresheimer (GXI TH) +1.3%
  • Diageo (GUI TH) +1.3%
  • Bayer (BAYN TH) +1.1%
  • Rio Tinto (RIO1 TH) +1.1%
  • Hermes (HMI TH) -1.3%
    • Watch Paris Stocks after Fitch Cuts France Outlook to Negative
  • Philips (PHI1 TH) -1.3%
  • AB InBev (1NBA TH) -1.3%
  • Tomra (TMRA TH) -1.3%
  • L’Oreal (LOR TH) -1.4%
    • L’Oreal’s Growth May Be Stuck Near-Term, Prefer Beiersdorf: Citi
  • Buzzi SpA (UCM TH) -1.5%
  • UMG (0VD TH) -1.6%
  • Lufthansa (LHA TH) -2.1%
    • Lufthansa CEO Says Fees Hurting German Airports, Bild Reports
  • Ryanair (RY4C TH) -2.5%
    • Ryanair Lower Profit View Baked In After Fares Reset: 2Q Preview
  • IAG (INR TH) -3.7%
    • China Eastern Pulls Madrid Flight as Subsidies Come Under Threat
    • Friday, British Airways Axes Some Long-Haul Flights Amid Engine Woes (1)

>>> TradeGate Pre-Market Indications

DAX:
  • Bayer (BAYN TH) +1.6%
    • Friday: Bayer Shares Slip on Latest Jury Ruling in Roundup Litigation
  • BASF (BAS TH) -1.2%
MDAX:
  • Gerresheimer (GXI TH) +1.8%
  • Thyssenkrupp (TKA TH) +1.6%
  • Aixtron (AIXA TH) +1.3%
  • RTL (RRTL TH) +1.2%
  • Puma (PUM TH) +1%
  • Lufthansa (LHA TH) -2%
    • Lufthansa CEO Says Fees Hurting German Airports, Bild Reports
SDAX:
  • Schaeffler (SHA TH) +6.8%
  • MLP (MLP TH) +2.4%
  • Kontron (KTN TH) +2.3%
  • Sixt (SIX2 TH) +1.1%
  • Deutz (DEZ TH) +1%
  • Deutsche PBB (PBB TH) -2.2%
    • Deutsche PBB Cut to Reduce at AlphaValue/Baader

>>> What to look at today - 14th of October 2024

Chinese shares fluctuated in a volatile session after a Finance Ministry briefing at the weekend underwhelmed investors and a drop in factory prices reinforced concerns about the economy. Onshore equities swung between gains and losses while Hong Kong shares dropped along with US stock futures. China’s yuan weakened against the greenback, as did the Australian and New Zealand dollars. Oil declined after China’s briefing lacked new incentives to boost consumption in the biggest importer. While China’s Finance Minister Lan Fo’an vowed more support for the real estate sector at the keenly anticipated weekend briefing, he did not produce a headline monetary stimulus figure, disappointing some investors. The focus is now turning to the next major policy briefing in the coming weeks — from the Communist Party-controlled parliament that oversees the budget — for details of more support.  Before the weekend briefing, money managers had been waiting for more fiscal measures to help sustain the rally sparked by the stimulus blitz that authorities unleashed in late September. Investors and analysts surveyed by Bloomberg had expected China to deploy as much as 2 trillion yuan ($283 billion) in fresh fiscal stimulus on Saturday, including potential subsidies, consumption vouchers and financial support for families with children. The CSI 300 Index, a benchmark of onshore equities, capped its biggest weekly loss since late July on Friday, while the Aussie and kiwi - proxies for China sentiment among developed market currencies - fell for two weeks running. In the commodities space, Brent dropped below $78 a barrel while iron ore futures in Singapore reversed an early decline. The US dollar advanced after rising for a second week as traders pared expectations on the pace of Federal Reserve rate cuts. The Monetary Authority of Singapore kept its monetary settings unchanged for a sixth consecutive review. This week, Chinese growth and retail sales data are due while inflation readings in New Zealand, Canada and the UK are expected. Thailand, Philippines and Indonesia central banks will give policy decisions ahead of the European Central Bank later this week.  The ECB will probably advance the global push for monetary easing with an interest-rate cut that policymakers had all but ruled out just a month ago.

Nikkei Closed Hang Seng -0.18% CSI +1.68% Shanghai +1.71% Shenzen +2.38%

Eur$ 1.0924 CNH 7.0836 CNY 7.0753 JPY 149.27 GBP 1.3059 CHF 0.8583 RUB 95.8044 TRY 34.2810 WTI$ 74.67 -1.18% Gold 2,659 +0.10% BTC 64,270 +2.44% ETH 2,359 +3.23%

S&P -0.06% Nasdaq -0.11% EuroStoxx +0.06% FTSE -0.10% Dax +0.18% SMI +0.16%

Macro :
- Fitch Cuts France's Outlook to Negative on Affirmed Rating -->French Bond Futures Soften After Fitch Gives Negative Outlook
- German Economy in Recession With No More Growth Seen in 2024
- China Says Major Disagreements Remain With EU Over EV Tariffs
- Goldman Sachs Upgrades China Growth Forecasts on Latest Stimulus
- Germany’s Social Democrats Weigh EV Subsidies in 2025 Strategy
- Chinese Equities Brace for Monday’s Negative Feedback Loop
- Hurricane Milton Was Intensified by Climate Change, Study Says
- Hedge Funds Buy US Stocks by Most Since 2021, Goldman Says
- Kenyan Chepngetich Sets Women’s World Record at Chicago Marathon
- UK Warned to Prepare for Floods After Unusually Wet September
- Bitcoin Jumps as Traders Weigh China Fiscal Stimulus, Trump Odds

Keep an eye on :
- AC FP : BTG asset manager buys Accor chain in Brazil for R$1.7 billion
- AKERBP NO : Aker BP 3Q Avg Production Meets Estimates
- ALV GY : *SINGAPORE WON'T ALLOW ALLIANZ-INCOME DEAL IN 'CURRENT FORM'
- AAPL US : Apple Prepares to Take the Smart Home Market Seriously: Power On
- BEI GY : L’Oreal’s Growth May Be Stuck Near-Term, Prefer Beiersdorf: Citi
- BA US : Boeing Sees $5b of Charges; to Cut Workforce by About 10%
- BA US : issues downside Q3 revenue guidance; making important strategic decisions to restore the company
- BOSN SW : Bossard 3Q Sales Misses Estimates
- CABK SM : CriteriaCaixa is on track to reach an agreement to sell Saba to Belgian company Interparking
- CVS US : CVS to Exit Core Infusions Services Business: Reuters
- DAZN : Saudi Arabia’s PIF Has No Plans to Invest in Blavatnik’s Dazn
- DNO NO : DNO 3Q Kurdistan Net Output 17,607 Boepd, North Sea 11,236 Boepd
- ENEL IM : Lula, Tarcísio and Nunes join forces and push for the end of Enel's concession after blackout in SP Sun, 13 Oct
- ENEL IM : Aneel calls meeting with Enel and companies that serve São Paulo after blackout leaves 1.2 million without power
- ENEL IM : TCNN Brazil: Silveira defends the expiration of Enel's concession in SP and calls the company to the emergency room
- FRA GY : Fraport Sept. Frankfurt Airport Passengers +1.2%
- FROG US : Software Tools Maker JFrog Said to Draw Takeover Interest
- GALP PL : Galp 3Q Refining Margin Misses Estimates
- HARL LN : Spain’s Navantia Close to Harland & Wolff Deal, Telegraph Says
- IPH FP : Innate Pharma Names Jonathan Dickinson as CEO From Nov. 1
- ISP IM : Intesa Fires ‘Disloyal’ Employee for Accessing Clients’ Data
- MUL LN : Frasers Group Sweetens Offer for Mulberry to 150 Pence/Share
- LDO IM : Leonardo, Rheinmetall to Announce Military JV Oct. 15, Sole Says
- OR FP : L’Oreal’s Growth May Be Stuck Near-Term, Prefer Beiersdorf: Citi
- LMT US : US Approves Possible $1.2B Military Sale to UAE
- LHA GY : Lufthansa CEO Says Fees Hurting German Airports, Bild Reports
- MC FP : LVMH: Kim Jones Is Stepping Down as Artistic Director of Womenswear and Couture at Fendi
- MUL LN : Mulberry Majority Owner Has ‘No Interest’ in Revised Frasers Bid
- ALCOX FP : Nicox and Soleus Sign $16.5M Royalty and Equity Financing
- NOVN SW : PE firms queue up for Novartis' Indian arm
- PFE US : Pfizer Wins US FDA Approval for Hympavzi in Hemophilia A or B
- RHM GY : Leonardo, Rheinmetall to Announce Military JV Oct. 15, Sole Says
- RIO LN : Rio Takes Step to M&A Redemption With $6.7 Billion Lithium Bet
- SCYR SM : Sacyr wins the Second Itata Route Concession in Chile with an investment of 516 million
- SAN FP : Lenders Prep Around €9.65 Billion for Sanofi Health Unit Buyout
- SIE GY : Siemens Pakistan Shares Rise 10% on Plan to Sell Energy Business
- SKAB SS : Skanska Signs Pact With Ingka Worth About SEK380m
- TLGO SM : Poland Seeks Spain’s Backing in Bid for Talgo: Business Insider
- TSLA US : SpaceX Wins Earlier-Than-Expected Approval to Fly Fifth Starship
- TIFS LN : ABC Technologies Raises Offer for TI Fluid to 200 Pence/Share
- TIFS LN : TI Fluid’s Latest Offer from ABC Still Looks Low: Jefferies
- 2330 TT : TSMC Plans More Chip Plants in Europe, Taiwan Official Says
- UPG BB : Unifiedpost to Sell Assets to Repay Francisco Partners Loan
- VEON US : Veon to Move Group HQ to Dubai From Amsterdam
- VOW GY : Germany’s Social Democrats Weigh EV Subsidies in 2025 Strategy

>>> Europe : Brokers Upgrades & Downgrades - 14th of October 2024

>>> Up
* Alfen Raised to Hold at Kepler Cheuvreux
* Bunzl Raised to Overweight at JPMorgan; PT 3,980 pence
* Dometic Raised to Hold at Nordea
* Equinor Raised to Equal-Weight at Morgan Stanley; PT 270 kroner
* Equinor ADRs Raised to Equal-Weight at Morgan Stanley; PT $25.80
* JPMorgan PT Raised to $240 from $225 at Wells Fargo
* Spirax Raised to Buy at Peel Hunt; PT 8,300 pence

>>> Down
* Arcadium Lithium Cut to Hold at TD Cowen; PT $5.85
* Caterpillar Cut to Underweight at Morgan Stanley; PT $332
* Compass Group Cut to Neutral at Citi; PT 2,650 pence
* Deutsche PBB Cut to Reduce at AlphaValue/Baader
* Hermes Cut to Market Perform at CICC; PT 2,000 euros
* Pluxee Cut to Sell at Goldman; PT 18 euros
* TI Fluid Cut to Hold at Investec; PT 200 pence

>>> Initiation
* Corem Property Rated New Buy at Pareto Securities
* Diamondback Resumed Neutral at Citi; PT $195
* Galp Rated New Buy at HSBC; PT 20 euros

>>> Call
* Compass Cut at Citi After Strong Run, Aramark Now Top Pick
* Equinor Raised, But Morgan Stanley Remains Cautious on Energy
* Goldman Sachs Upgrades China Growth Forecasts on Latest Stimulus
* Hedge Funds Buy US Stocks by Most Since 2021, Goldman Says
* L’Oreal’s Growth May Be Stuck Near-Term, Prefer Beiersdorf: Citi
* TI Fluid’s Latest Offer from ABC Still Looks Low: Jefferies
* Wizz Air Gets Street-Low Price Target as Citi Sees Weak Results

WWD : What’s Next for Fendi After Kim Jones’ Departure?

What’s Next for Fendi After Kim Jones’ Departure?
Jones has stepped down at the Italian brand, which is said to be in talks with several potential successors, including Pierpaolo Piccioli.

PARIS — Yet another high-profile design vacancy opened Friday when Fendi revealed that Kim Jones would step down after four eventful years as artistic director of haute couture, ready-to-wear and fur collections for women.

He will “now concentrate fully on his role of artistic director at Dior Men’s,” the Roman house said in a brief statement issued late Friday.

The development comes amid fevered — and often spurious — speculation about the vast game of musical chairs playing out at the highest echelons of European fashion.

There was no mention of the succession plan, only that “a new creative organization for Fendi” would be announced “in due time.”

According to market sources, Fendi has recently held discussions with designers including Pierpaolo Piccioli, previously creative director of Valentino.

In Friday’s statement, the focus was on Jones’ tenure, which brought collaborations and destination shows into the mix.

“Kim Jones made significant contributions to the brand’s creative legacy, seamlessly integrating his modern and cross-cultural aesthetics with Fendi’s historical heritage,” it said. “Under his leadership, the maison reinvented its ready-to-wear and couture collections, offering an inclusive and innovative approach to fashion that constantly renewed Fendi’s Italian codes. Throughout his four years, Jones’ work was wholly guided by passion and creativity.”

Bernard Arnault, chairman and chief executive officer of LVMH Moët Hennessy Louis Vuitton, lauded Jones as “a highly talented designer who has brought his unique and multicultural vision to Fendi over the past four years. I would like to thank him for his contribution and look forward to continuing to witness his creativity for Dior Men’s.”

Jones was one of the rare designers to straddle two luxury brands in two countries.

Still, his exit from Fendi adds to the creative upheaval roiling the industry, currently grappling with a slowdown in luxury consumption and consumer caution.

As reported, the employment contracts of John Galliano at Maison Margiela, Jonathan Anderson at Loewe, and Lucie and Luke Meier at Jil Sander are coming to term before the end of the year or in early 2025, according to market sources. There are also creative vacancies at Chanel, Dries Van Noten and Jean Paul Gaultier.

During his tenure at Fendi, Jones frequently referenced ready-to-wear designed by Karl Lagerfeld, who had famously created furs and women’s rtw for the Roman house from 1965 until his death in 2019.

Jones also collaborated closely with Silvia Venturini Fendi, artistic director of accessories and menswear collections, and her daughter Delfina Delettrez Fendi, jewelry creative director, whom he considered a key muse.

Over the past year he spoke enthusiastically about preparations for Fendi’s centenary in 2025, while stopping short of detailing specific plans.

When he joined Fendi, Jones became the latest acclaimed menswear specialist to broaden his fashion universe to womenswear, following on the heels of Hedi Slimane and Raf Simons.

For his first crack at Fendi, he took a client-focused approach centered on real clothes and the lifestyle needs of his close circle of female friends, which includes the likes of Kate Moss, Naomi Campbell, Ronnie Cooke Newhouse and Victoria Beckham.

He told WWD in an interview ahead of his Fendi rtw debut in February 2021 that he simply wanted to make “clothes that women will want to buy. I’m not gonna lie — I think that’s what my job is. I want all my friends to go, ‘I want that straight away.’”

He took pride in commercial success, and frequently boasted that Fendi revenues grew during his tenure to surpass 2 billion euros.

His collections received mostly positive, though hardly ecstatic, reviews, and it is understood some LVMH insiders looked dimly on some of his projects at Fendi.

In September 2021, he surprised the fashion world by pioneering a full creative swap: Donatella Versace designed a Fendi collection and Jones a Versace lineup for pre-fall 2022 retailing. They were known collectively as the Fendace collections and were sold at pop-ups across the globe, in addition to the Versace and Fendi websites and boutiques.

In 2022, Jones tapped Marc Jacobs to create a collection within Fendi’s spring 2023 women’s collection that was shown during New York Fashion Week, and also teamed with Tiffany & Co. for special Baguette handbags. He followed up in 2023 with a Stefano Pilati collaboration under the new “Friends of Fendi” banner.

Jones also endured some management turmoil during his four-year stint.

Last May, Pierre-Emmanuel Angeloglou was appointed CEO of the Italian luxury company, which he took on in addition to his role as managing director of LVMH Fashion Group.

He succeeded Serge Brunschwig, who served for six years as chairman and CEO of Fendi, building the brand’s retail network, investing in its industrial infrastructure, and forging a joint venture with Design Holding, forming Fashion Furniture Design (FF Design) to develop the Fendi Casa business.

A veteran of LVMH, Jones came on board in 2011 as men’s artistic director at Louis Vuitton, parlaying his zest for exotic travel into ultra-luxurious collections with understated cool and sly functionality. He helped ignite the luxury streetwear phenomenon with the landmark 2017 collaboration with Supreme, the cult New York skatewear brand.

Since joining the men’s division of Dior in 2018, Jones has stepped up the pace of collaborations, mostly with fine artists including Daniel Arsham, Kaws and Amoako Boafo, but also the surfwear maven Shawn Stussy, and the Jordan brand. The latter yielded one of the most sought-after sneakers of 2020, the Air Jordan 1 OG Dior limited-edition.

Jones has had a storied fashion career, with Galliano snapping up his graduate collection from Central Saint Martins.

He initially launched a signature menswear label. Known for its sporty, streetwear edge, the Kim Jones brand lasted for eight seasons and attracted the attention of Dunhill, where he was creative director from 2008 to 2011.

WWD : Mulberry Owner Challice Rejects Fresh Bid, Tells Frasers to Walk Away

Mulberry Owner Challice Rejects Fresh Bid, Tells Frasers to Walk Away
Challice Ltd. has rejected a new bid proposal by Frasers Group, saying it remains "very supportive" of Mulberry, and that it's not the right time to sell.

LONDON — Mulberry’s majority owner Challice Ltd. has asked Frasers Group to cease its pursuit of the accessories brand, and said any attempt at a takeover will fail.

Challice was responding to Frasers’ updated offer for the company, which was lodged after the market closed on Friday. Frasers has increased its proposed cash offer to about 111 million pounds from 83 million pounds, equivalent to 1.50 pounds for each Mulberry share.

In response, Challice reiterated its support for Mulberry, argued that it was an “inopportune time” for the company to be sold, and asked Frasers to walk away.

Challice, which is controlled by the Singapore-based Ong Beng Seng and his wife Christina Ong, described Frasers as a “supportive minority shareholder,” but said it has “no interest” in either selling its Mulberry shares to Frasers, or providing Frasers with any undertakings with regard to its possible offer.

It was the second time in less than two weeks that Challice has rebuffed Frasers, which made its first play for the loss-making Mulberry in late September.

Per stock exchange rules, Frasers has to deliver a firm and final offer to the Mulberry board, or announce that it does not intend to make an offer, by no later than 5 p.m. London time on Oct. 28.

In its statement, Challice described Frasers’ advances as “distracting” both to the company and its management.

Challice also noted that Frasers would need to secure control of more than 50 percent of the issued Mulberry shares for any offer to be successful. Challice, which holds a 56.4 percent stake in Mulberry, argued that without its support, any offer would fail.

“Challice hopes that by making its position clear, Frasers will be encouraged to announce that it does not intend to make an offer for Mulberry,” the statement said.

Challice, which has been a majority shareholder in Mulberry since 2002, has been down this road before with Frasers. This is the second time in four years that Frasers, which was founded and is ultimately controlled by retail tycoon Mike Ashley, has made a run at Mulberry.

In 2020, Ashley built up a stake so high that he was forced to make a bid or leave the company. He eventually walked away.

Ashley specializes in buying stakes in distressed companies, or in companies such as Mulberry, which sell through his retail chains.

On Friday, Frasers said it was flummoxed as to why its original offer was rejected.

Frasers described Mulberry’s latest financial results as “catastrophic,” and said it strongly believes it can provide the “appropriate insulation and investment to support a much-loved British brand. As part of the Frasers portfolio, the Mulberry brand would be provided with the platform to ensure its long-term survival and success.”

Frasers hasn’t exactly proven itself as a great caretaker of luxury brands.

Late last year, it purchased Matches at a knockdown price of 52 million pounds, and then placed it into administration shortly afterward. Frasers bought back the IP, and administrators sold off millions of pounds of fashion stock, leaving many of Matches’ designers and brands trying to recoup their losses.

Having originally touted the Matches purchase and positioned itself as the troubled company’s savior, Frasers quickly concluded that Matches was too expensive to bankroll against a backdrop of dwindling luxury demand, and a cost-of-living crisis.

In the last fiscal year, Mulberry reported a 4 percent decline in sales, and swung to a loss before tax of 34.1 million pounds.

Challice has acknowledged the challenges it is facing with Mulberry, and has also underwritten a capital raise of 10.75 million pounds to help restore the brand’s fortunes and deliver value to shareholders.

Frasers has challenged Challice’s strategy, saying it has “significant reservations” that the new capital raised would be enough to support the business through the near to medium-term.

“It is Frasers’ belief that this will lead likely to another capitalization event … unless there is immediate and very real change at the company,” it said.

WWD : Vestiaire Collective Celebrates 15th Anniversary With Luxury Goods Treasur

Vestiaire Collective Celebrates 15th Anniversary With Luxury Goods Treasure Hunt
The luxury resale pioneer will release 250 luxury items for just $15, as it moves to take a more active role in helping to shape fashion circularity and policy.


PARIS — With 15 years under its stylish belt, luxury resale pioneer Vestiaire Collective is celebrating its anniversary with a curated drop of 250 pieces priced at under $15.

It will be a treasure hunt for buyers, with a Fendi Baguette bag, a Dior Saddle belt pouch, a Louis Vuitton Neverfull tote and a Bottega Veneta bag on offer, alongside items from brands including Gucci, Chloé and Burberry.

The move comes as the company continues to expand its work in growing the resale and circular fashion sector. The latter three brands are long-standing partners of Vestiaire Collective, which has helped to build the resale game over its decade-and-a-half in business as one of the first movers in the online resale market.

“We made circular fashion a big thing, and that’s what I’m very proud of,” cofounder and president Fanny Moizant claimed. “We’ve seen interest and desire for people to consume differently.”

Launched in 2009, Vestiaire Collective’s growth bears that out: revenue in 2023 was up 25 percent to 157 million euros, on 824 million euros of gross merchandise value. Moizant chalked up the increase to new memberships more than an increase in basket value.

The U.S. is now the French company’s largest market, representing more than 20 percent of its activity, and sales there were up 57 percent year-over-year since 2019. With chief executive officer Maximilian Bittner based in the U.S. since last September, the company is focused on continued growth in the region.

A recent storyline on Netflix’s “Emily in Paris” that involved Vestiaire is poised to further boost business. The episode resulted in a 30 percent increase in search. That was accompanied by “big, big spikes” of new registrations and listings, which jumped 30 percent in Europe and 42 percent in the U.S.

“We are very hopeful that maybe the hardest job has been done, and we are on the path to conquer that market and to be even more successful in the future,” Moizant said.

Globally the used clothing market hit $43 billion in 2023, up from $23 billion in 2018, and grew about seven times faster than the overall retail industry according to a recent study by platform ThredUp. With consumers increasingly aware of and open to resale, Vestiaire aims to continue to shift the sustainability conversation around fashion.

“The first 10 years were dedicated to growing the business, and at some point, we really focused on making sure the house was clean,” Moizant said. The company gained B Corp status and partnered with nonprofit The Or Foundation, among other milestones. Now Vestiaire’s bold mission is to change the industry itself.

Moizant and cofounder Sophie Hersan started with listing just 3,000 items, mostly sourced from friends and family — now the company has sold more than 12 million. Much of that haul is handbags, with Vestiaire tallying more than 2.6 million handbags sold over the years.

The company’s research indicates that 80 percent of secondhand purchases on Vestiaire are instead of a firsthand purchase, which means about 10 million new items not purchased. Their data shows that model has saved more than 300,000 tons of carbon emissions, and diverted more than 4,800 tons of raw materials and 2.9 billion gallons of water from use.

Kering’s investment in the company in 2021 was a “critical, massive step” toward industry acceptance, Moizant said, and represented a new way of thinking about the fashion system. If a luxury conglomerate can see the value in secondhand, brands and buyers could, too, the reasoning went.

Big names jumped on board as partners, including Gucci, Burberry, Chloé and Courrèges. Vestiaire also attracted high-profile, self-professed fans with Jessica Chastain, Jessica Alba and Kim Kardashian touting their use of the site.

Last year’s AI-generated ad campaign featuring piles of clothing in front of global landmarks including the Eiffel Tower and Times Square has been among the biggest successes in communicating the company’s message, Moizant said.

“The campaign was basically putting the problem of over-consumption and the waste [it creates] on your doorstep,” she said. It was a turning point for the company and more effective than showing mountains of waste in the dumps of the global south. Sustainability messaging walks a fine line between promoting your business without greenwashing, and educating without admonishing, she said.

“It was another step to touch them personally, and almost physically, to imagine, what if that waste was on my doorstep? That campaign went completely nuts, in a good way,” she said of its viral reach.

The next iteration will be the company’s continued forays into policy making, pushing to decrease the value added tax on commissions, which increases the prices for buyers of secondhand fashion, at the French and European Commission level. With affordability being top-of-mind for consumers, this is an increasingly important topic for Vestiaire.

“We’ve also involved lobbying in our thinking and to be even closer to our mission. In the last five years, while we were scaling, we were going even deeper into our mission and vision, while not forgetting who we are,” said Moizant.

The company is now planning an additional program with The Or Foundation, which works on changing the current fashion business model and focuses on clothing waste. Moizant said the next project will include bringing “another piece of the industry” to Ghana, which imports about 15 million items of secondhand clothing each week, causing extreme environmental impacts.

The third round of the company’s “fast fashion ban” — which included Asos, Boohoo, Shein and Topshop in its initial round in 2022, and expanded to H&M, Gap Inc., Mango, Uniqlo and Zara last year — will be revealed in early November.

The company signed on to a petition launched by American Circular Textiles group addressing taxation on resale earlier this summer, and is working on publishing an open letter on the topic of fast fashion before the end of the year.

“We are trying to move the needle…to make sure we have the biggest impact,” Moizant said about the company moving into more political action.

The new drop is intended to keep Vestiaire’s unique balance. “We really keep it in our DNA to be activist, but at the same time quite playful and quite engaging in the way we operate the business,” she said. “Vestiaire is very playful as a platform. This campaign is hitting both of those values.”

The drop will feature dedicated items for the Asia, Europe and U.S. markets. The selection will be available for under $15 (or pounds, or euros, depending on the region) and will go live worldwide at noon CET on Tuesday.

FT : Pfizer has problems an activist can’t fix

Pfizer has problems an activist can’t fix
Not quickly, anyway

Pfizer and Starboard
The FT coverage of the Starboard Value-Pfizer affair has been a lot of fun to read. A week ago we learned that the activist investor had built up a $1bn stake in the drug company — market cap $165bn — and that former Pfizer CEO Ian Read and former CFO Frank D’Amelio had pitched current CEO Albert Bourla and several board members on the activists’ plan. Last Tuesday it came out that Bourla was set to meet with Starboard, and it looked like the activists had Pfizer on the back foot. But then on Thursday it turned out that Read and D’Amelio had had second thoughts and were “fully supportive” of Bourla and the board. 

The final morsel to drop was the fact that Bourla had found out that Starboard was circling from what appeared to be a fat finger email from D’Amelio — with no message — that cc’d a representative of Starboard. Starboard had planned to announce its investment at a conference later this month. Oopsie. 

Over in the Lex column, my colleague Pan Yuk has already pointed out the reason why Pfizer might look like a target for activists. The share price has been falling since Pfizer’s blockbuster Covid vaccines stopped bringing in big revenues. The stock is cheap compared to peers’. The company spent much of the vaccine windfall on the $44bn acquisition of Seagen in March last year, which has yet to pay off. Yuk also points out, however, that while Pfizer is in need of a turnaround, it is not at all clear what can be done. She’s right — but there may be one thing that would work for Starboard. 

Some context first. Below is a list of the 15 largest pharma companies in the world, along with their price/earnings valuations, and expected revenue and earnings per share growth for the next 3 years:

The reason Pfizer is cheap is clear. It isn’t growing. Revenues are expected to grow at a sub-inflation 1 per cent rate over the next three years; earnings per share growth (supported by some cost cutting and share buybacks, presumably) are expected to average 5 per cent, among the very lowest in the group.

Low growth is not an easy problem to fix in pharma. Most of the time, pharma companies grow because their drugs work, and that depends on science, not corporate finance. Maybe the Seagen acquisition will pay off in the end, or maybe other pipeline candidates will come good. But Starboard can’t control clinical trials. 

It is worth remembering that 15 years ago, Lilly, now the biggest pharma company in the world and still growing fast, was struggling mightily to grow as patents expired and one clinical program after the other went wrong. It had a P/E ratio of 8. Ten years ago, on the other hand, Bristol-Meyers’ cancer drug portfolio was the envy of the industry, its stock was on a rip, and it had a P/E ratio over 40. Now Bristol is looking at falling revenues and is the cheapest big pharma stock (and was, not coincidentally, the target of an unsuccessful Starboard activist campaign in 2019). Fortunes change slowly in pharma, and in unpredictable ways. 

With that said, what can Starboard ask for that might help? A few ideas:

  1. Allocate capital differently. Over the past five years — that is, since Bourla has been CEO — Pfizer has generated $98bn in operating cash flow. It has spent $77bn on cash acquisitions, $43bn on dividends, $14bn on capital expenditures, and $11bn on share repurchases (readers who are quick at arithmetic will notice that cash outgoings have exceeded incomings by $48bn or so; this is part of the problem). Cutting the dividend is probably a non-starter for the market. An activist who suggested buying back fewer shares because the stock was so cheap would be caught in something of a contradiction. One could call on Pfizer to do fewer acquisitions and focus on in-house R&D, but that is a project that would take, oh, a decade or two to bear fruit, which is a lot longer than Starboard will want to hang around. 
  2. Run the company more tightly. Too late. The company has been pushing a multibillion-dollar cost-cutting plan since 2023.
  3. Sell stuff. Too late again. The consumer health and animal health units are gone. Pfizer is already selling down its stake in the consumer health company Halion. It might be able to sell its minority stake in Viiv, which makes HIV medication, to the other partners in the joint venture for a few billion dollars, though.  
  4. Fire Bourla. I have no view on whether Bourla has done a good job or not. But if Starboard’s view is that the strategy is wrong, or the company has proven to be poor at M&A, or that capital allocation is suboptimal, or that the company is dragging its feet on the cost-cutting plan, the fastest way for them to prove to the market that things are really different now is to get the boss sacked, and take a few board members with him. I just don’t see what other needle-moving announcements there are for Starboard to make. Am I being insufficiently imaginative? 

Even a new management team and (say) some turnover on the board might not move Pfizer’s stock a ton. But if Starboard could move the shares, say, 10 per cent, they might take their $100mn gain and go home.